Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism

ClinicalTrials.gov ID: NCT05412979

Public ClinicalTrials.gov record NCT05412979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Crossover, Phase 2 Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism

Study identification

NCT ID
NCT05412979
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sention Therapeutics, LLC
Industry
Enrollment
490 participants

Conditions and interventions

Conditions

Interventions

  • ST-1891 Drug
  • Levothyroxine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2022
Primary completion
Oct 3, 2023
Completion
Oct 3, 2023
Last update posted
Aug 25, 2024

2022 – 2023

United States locations

U.S. sites
39
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Sention Investigational Site Greenbrae California 94904
Sention Investigational Site Newhall California 91321
Sention Investigational Site Denver Colorado 80246
Sention Investigational Site Fort Lauderdale Florida 33312
Sention Investigational Site Jacksonville Florida 32258
Sention Investigational Site New Port Richey Florida 34652
Sention Investigational Site Palm Harbor Florida 34684
Sention Investigational Site Atlanta Georgia 30318
Sention Investigational Site Lawrenceville Georgia 30046
Sention Investigational Site Roswell Georgia 30076
Sention Investigational Site Evergreen Park Illinois 60805
Sention Investigational Site Newburgh Indiana 47630
Sention Investigational Site South Bend Indiana 46617
Sention Investigational Site Ankeny Iowa 50023
Sention Investigational Site Louisville Kentucky 40213
Sention Investigational Site Dearborn Michigan 48126
Sention Investigational Site Chesterfield Missouri 63017
Sention Investigational Site Jefferson City Missouri 65109
Sention Investigational Site Staten Island New York 10301
Sention Investigational Site Cary North Carolina 27518
Sention Investigational Site Greenville North Carolina 27834
Sention Investigational Site Hickory North Carolina 28601
Sention Investigational Site Morehead City North Carolina 28557
Sention Investigational Site Raleigh North Carolina 27609
Sention Investigational Site Rocky Mount North Carolina 27804
Sention Investigational Site Salisbury North Carolina 28144
Sention Investigational Site Wilmington North Carolina 28401
Sention Investigational Site Mt. Pleasant South Carolina 29464
Sention Investigational Site Bristol Tennessee 37620
Sention Investigational Site Chattanooga Tennessee 37411
Sention Investigational Site Memphis Tennessee 38133
Sention Investigational Site Austin Texas 78731
Sention Investigational Site Austin Texas 78749
Sention Investigational Site Benbrook Texas 76132
Sention Investigational Site Live Oak Texas 78233
Sention Investigational Site Round Rock Texas 78681
Sention Investigational Site Webster Texas 77598
Sention Investigational Site Virginia Beach Virginia 23462
Sention Investigational Site Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05412979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05412979 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →